These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6416050)

  • 1. Improved tolerance with two radiation fractions per day for treatment of abdominal and pelvic malignancies.
    Loeffler RK
    Am J Clin Oncol; 1983 Dec; 6(6):619-27. PubMed ID: 6416050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial.
    Chen GY; Jiang GL; Qian H; Wang LJ; Yang HJ; Fu XL; Wu KL; Zang Z; Zhao S
    Radiother Oncol; 2004 May; 71(2):157-62. PubMed ID: 15110448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-abdominal radiation in endometrial carcinoma: an analysis of toxicity, patterns of recurrence, and survival.
    Small W; Mahadevan A; Roland P; Vallow L; Zusag T; Fishman D; Massad S; Rademaker A; Kalapurakal JA; Chang S; Lurain J
    Cancer J; 2000; 6(6):394-400. PubMed ID: 11131490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
    Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute toxicity of curative radiotherapy in elderly patients.
    Huguenin P; Glanzmann C; Lütolf UM
    Strahlenther Onkol; 1996 Dec; 172(12):658-63. PubMed ID: 8972750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
    Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
    Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on clinical application of multiple fractions per day radiation therapy with concomitant boost technique for esophageal cancer].
    Kikuchi Y
    Hokkaido Igaku Zasshi; 1993 Jul; 68(4):537-56. PubMed ID: 8340051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radiation injury of the small intestine. Radiobiological, radiopathological aspects; risk factors and prevention].
    Touboul E; Balosso J; Schlienger M; Laugier A
    Ann Chir; 1996; 50(1):58-71. PubMed ID: 8734278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal complications after external megavoltage treatment.
    Nordman EM; Valavaara RA
    Strahlentherapie; 1978 Jan; 154(1):16-9. PubMed ID: 415383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of radiotherapy in combined therapy of soft tissue sarcoma in children and adolescents].
    Golubicić I; Nikitović M; Bokun J; Gavrilović D; Radosević-Jelić Lj
    Srp Arh Celok Lek; 2000; 128(5-6):172-8. PubMed ID: 11089417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
    Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
    Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High energy (42-66 MeV reactions) fast neutron dose optimization studies in the head and neck, thorax, upper abdomen, pelvis and extremities.
    Griffin TW; Martz KL; Laramore GE; Thomas FJ; Maor MH; Hendrickson FR; Parker RG; Richter MP; Davis LW
    Radiother Oncol; 1990 Dec; 19(4):307-16. PubMed ID: 2126633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of neutron radiotherapy treatment complications.
    Griffin T; Pajak T; Laramore G; Davis L
    Bull Cancer; 1986; 73(5):582-6. PubMed ID: 3096403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early tolerance of different organs to fast fractionation in clinical practice.
    Kovarik J; Svoboda VH
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1451-4. PubMed ID: 7635787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical radiobiology of stage T2-T3 bladder cancer.
    Majewski W; Maciejewski B; Majewski S; Suwinski R; Miszczyk L; Tarnawski R
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):60-70. PubMed ID: 15337540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative electron irradiation in the management of pediatric malignancies.
    Schomberg PJ; Gunderson LL; Moir CR; Gilchrist GS; Smithson WA
    Cancer; 1997 Jun; 79(11):2251-6. PubMed ID: 9179074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing cancer radiotherapy with 2-deoxy-d-glucose dose escalation studies in patients with glioblastoma multiforme.
    Singh D; Banerji AK; Dwarakanath BS; Tripathi RP; Gupta JP; Mathew TL; Ravindranath T; Jain V
    Strahlenther Onkol; 2005 Aug; 181(8):507-14. PubMed ID: 16044218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.